Faeth Therapeutics, Inc. (FTH) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$20.45M | +17.1% |
| 2024 | -$24.67M | +23.0% |
| 2023 | -$32.02M | +17.9% |
| 2022 | -$39.03M | -29.0% |
| 2021 | -$30.26M | -70.9% |
| 2020 | -$17.70M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$20.45M | +17.1% |
| 2024 | -$24.67M | +23.0% |
| 2023 | -$32.02M | +17.9% |
| 2022 | -$39.03M | -29.0% |
| 2021 | -$30.26M | -70.9% |
| 2020 | -$17.70M | — |